Valeo Financial Advisors, LLC Crispr Therapeutics Ag Transaction History

Valeo Financial Advisors, LLC

$3.34 Billion
Q1 2024

A detailed history of Valeo Financial Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 9,379 shares of CRSP stock, worth $506,559. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,379

Previous 9,379 -0.0%

Holding current value

$506,559

Previous $639,000 -0.0%

% of portfolio

0.02%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$60.67 - $89.12 $30,152 - $44,292	-497 Reduced 5.03%	9,379 $639,000
Q4 2023 Jan 29, 2024	SELL	$38.62 - $72.18 $21,241 - $39,699	-550 Reduced 5.28%	9,876 $618,000
Q3 2023 Oct 19, 2023	BUY	$45.39 - $59.0 $155,687 - $202,370	3,430 Added 49.03%	10,426 $473,000
Q2 2023 Jul 14, 2023	SELL	$43.47 - $67.77 $102,676 - $160,072	-2,362 Reduced 25.24%	6,996 $392,000
Q1 2023 Apr 17, 2023	BUY	$41.0 - $56.12 $94,833 - $129,805	2,313 Added 32.83%	9,358 $423,000

Q4 2022 Feb 09, 2023	BUY	$39.19 - $65.67 $11,678 - $19,569	298 Added 4.42%	7,045 $286,000
Q3 2022 Oct 31, 2022	SELL	$61.1 - $83.78 $171,080 - $234,584	-2,800 Reduced 29.33%	6,747 $441,000
Q2 2022 Aug 03, 2022	BUY	$43.23 - $73.83 $27,580 - $47,103	638 Added 7.16%	9,547 $580,000
Q1 2022 Apr 28, 2022	BUY	$53.19 - $79.24 $77,178 - $114,977	1,451 Added 19.46%	8,909 $559,000
Q4 2021 Jan 07, 2022	BUY	$70.09 - $111.29 $99,527 - $158,031	1,420 Added 23.52%	7,458 $565,000
Q3 2021 Nov 02, 2021	BUY	$110.2 - $156.64 $42,096 - $59,836	382 Added 6.75%	6,038 $676,000
Q2 2021 Jul 22, 2021	SELL	$100.84 - $161.89 $504 - $809	-5 Reduced 0.09%	5,656 $916,000
Q1 2021 Apr 12, 2021	BUY	$110.72 - $210.04 $213,025 - $404,116	1,924 Added 51.49%	5,661 $690,000
Q4 2020 Feb 11, 2021	SELL	$79.67 - $173.23 $13,145 - $28,582	-165 Reduced 4.23%	3,737 $572,000
Q3 2020 Oct 28, 2020	BUY	$78.5 - $100.64 $2,590 - $3,321	33 Added 0.85%	3,902 $326,000
Q2 2020 Jul 20, 2020	BUY	$38.5 - $76.05 $118,041 - $233,169	3,066 Added 381.82%	3,869 $284,000
Q1 2020 Apr 13, 2020	BUY	$33.68 - $62.53 $1,785 - $3,314	53 Added 7.07%	803 $37,000
Q4 2019 Jan 24, 2020	BUY	$36.68 - $73.13 $4,034 - $8,044	110 Added 17.19%	750 $46,000
Q3 2019 Oct 15, 2019	SELL	$40.99 - $52.56 $3,484 - $4,467	-85 Reduced 11.72%	640 $26,000
Q1 2019 Apr 12, 2019	BUY	$28.02 - $40.87 $8,462 - $12,342	302 Added 71.39%	725 $26,000
Q4 2018 Jan 30, 2019	BUY	$22.73 - $42.34 $1,000 - $1,862	44 Added 11.61%	423 $12,000
Q3 2018 Nov 01, 2018	BUY	$44.35 - $65.71 $13,038 - $19,318	294 Added 345.88%	379 $12,000
Q2 2018 Aug 14, 2018	SELL	$42.62 - $73.59 $852 - $1,471	-20 Reduced 19.05%	85 $4,000
Q1 2018 Apr 12, 2018	SELL	$23.52 - $58.17 $588 - $1,454	-25 Reduced 19.23%	105 $5,000
Q4 2017 Feb 09, 2018	BUY	$16.95 - $23.48 $1,017 - $1,408	60 Added 85.71%	130 $3,000
Q3 2017 Nov 15, 2017	BUY	$16.75 - $20.66 $1,172 - $1,446	70	70 $1,000

Others Institutions Holding CRSP

# of Institutions

549

Shares Held

56.3M

Call Options Held

2.91M

Put Options Held

2.47M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.21B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Account

Valeo Financial Advisors, LLC Crispr Therapeutics Ag Transaction History